Technical Analysis for NVCT - Nuvectis Pharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 6.50 | -0.15% | -0.01 |
NVCT closed down 0.15 percent on Friday, April 26, 2024, on 21 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Spinning Top | Other | -0.15% | |
| Stochastic Reached Oversold | Weakness | -0.15% | |
| Outside Day | Range Expansion | -0.15% | |
| Wide Bands | Range Expansion | -0.15% | |
| Oversold Stochastic | Weakness | -0.15% |
| Alert | Time |
|---|---|
| Down 1% | about 7 hours ago |
| Possible NR7 | about 8 hours ago |
| Possible Inside Day | about 8 hours ago |
| 60 Minute Opening Range Breakout | about 9 hours ago |
| Up 1% | about 9 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2024
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of targeted small molecule therapeutics for the treatment of cancer. The company develops NXP800, an oral small molecule inhibitor of the Heat Shock Factor 1 pathway, a signaling pathway in the initiation and progression of various cancers; and NXP900 program, an oral small molecule designed to inhibit the SRC and YES1 kinases. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Life Sciences Biology Treatment Of Cancer Tyrosine Kinase Oncogenes Cancer Research Small Molecule Kinase Proto Oncogene Tyrosine Protein Kinase Src
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Life Sciences Biology Treatment Of Cancer Tyrosine Kinase Oncogenes Cancer Research Small Molecule Kinase Proto Oncogene Tyrosine Protein Kinase Src
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.65 |
| 52 Week Low | 6.21 |
| Average Volume | 100,117 |
| 200-Day Moving Average | 10.14 |
| 50-Day Moving Average | 8.36 |
| 20-Day Moving Average | 7.20 |
| 10-Day Moving Average | 6.71 |
| Average True Range | 0.67 |
| RSI (14) | 36.31 |
| ADX | 15.26 |
| +DI | 13.92 |
| -DI | 20.27 |
| Chandelier Exit (Long, 3 ATRs) | 6.74 |
| Chandelier Exit (Short, 3 ATRs) | 8.30 |
| Upper Bollinger Bands | 8.33 |
| Lower Bollinger Band | 6.08 |
| Percent B (%b) | 0.19 |
| BandWidth | 31.25 |
| MACD Line | -0.53 |
| MACD Signal Line | -0.51 |
| MACD Histogram | -0.0178 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.77 | ||||
| Resistance 3 (R3) | 6.78 | 6.69 | 6.73 | ||
| Resistance 2 (R2) | 6.69 | 6.62 | 6.69 | 6.71 | |
| Resistance 1 (R1) | 6.60 | 6.58 | 6.56 | 6.59 | 6.69 |
| Pivot Point | 6.51 | 6.51 | 6.49 | 6.51 | 6.51 |
| Support 1 (S1) | 6.42 | 6.44 | 6.38 | 6.41 | 6.31 |
| Support 2 (S2) | 6.33 | 6.40 | 6.33 | 6.29 | |
| Support 3 (S3) | 6.24 | 6.33 | 6.28 | ||
| Support 4 (S4) | 6.23 |
